While E-cadherin expression is commonly described as non-abundant or absent in gliomas and GBM [41], our data showed E-cadherin expression in all three malignant cell lines (LN229, U251, U343) and an absence in the hA. This evidence concerns the gene CDH1 and central nervous system cancer.